Ribeiro JR - Search Results

1

Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers.

Cavalcante L, Deshmukh SK, Ribeiro JR, Carneiro BA, Dizon DS, Angara K, Mattox T, Wu S, Xiu J, Walker P, Oberley M, Nabhan C, Huang H, Antonarakis ES. Cavalcante L, et al. Among authors: ribeiro jr. JCO Precis Oncol. 2023 Sep;7:e2300088. doi: 10.1200/PO.23.00088. JCO Precis Oncol. 2023. PMID: 37677121

2

Multiomic Characterization Reveals a Distinct Molecular Landscape in Young-Onset Pancreatic Cancer.

Ogobuiro I, Baca Y, Ribeiro JR, Walker P, Wilson GC, Gulhati P, Marshall JL, Shroff RT, Spetzler D, Oberley MJ, Abbott DE, Kim HJ, Kooby DA, Maithel SK, Ahmad SA, Merchant NB, Xiu J, Hosein PJ, Datta J. Ogobuiro I, et al. Among authors: ribeiro jr. JCO Precis Oncol. 2023 Sep;7:e2300152. doi: 10.1200/PO.23.00152. JCO Precis Oncol. 2023. PMID: 37944072 Free PMC article.

3

Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases.

In GK, Ribeiro JR, Yin J, Xiu J, Bustos MA, Ito F, Chow F, Zada G, Hwang L, Salama AKS, Park SJ, Moser JC, Darabi S, Domingo-Musibay E, Ascierto ML, Margolin K, Lutzky J, Gibney GT, Atkins MB, Izar B, Hoon DSB, VanderWalde AM. In GK, et al. Among authors: ribeiro jr. NPJ Precis Oncol. 2023 Nov 14;7(1):120. doi: 10.1038/s41698-023-00471-z. NPJ Precis Oncol. 2023. PMID: 37964004 Free PMC article.

4

The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes.

James NE, Emerson JB, Borgstadt AD, Beffa L, Oliver MT, Hovanesian V, Urh A, Singh RK, Rowswell-Turner R, DiSilvestro PA, Ou J, Moore RG, Ribeiro JR. James NE, et al. Among authors: ribeiro jr. Sci Rep. 2020 May 22;10(1):8558. doi: 10.1038/s41598-020-65353-x. Sci Rep. 2020. PMID: 32444701 Free PMC article.

5

HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression.

Rowswell-Turner RB, Singh RK, Urh A, Yano N, Kim KK, Khazan N, Pandita R, Sivagnanalingam U, Hovanesian V, James NE, Ribeiro JR, Kadambi S, Linehan DC, Moore RG. Rowswell-Turner RB, et al. Among authors: ribeiro jr. J Immunol. 2021 May 15;206(10):2478-2488. doi: 10.4049/jimmunol.2000281. Epub 2021 Apr 26. J Immunol. 2021. PMID: 33903172

6

Targeting TBP-Associated Factors in Ovarian Cancer.

Ribeiro JR, Lovasco LA, Vanderhyden BC, Freiman RN. Ribeiro JR, et al. Front Oncol. 2014 Mar 11;4:45. doi: 10.3389/fonc.2014.00045. eCollection 2014. Front Oncol. 2014. PMID: 24653979 Free PMC article. Review.

7

Tetrathiomolybdate mediates cisplatin-induced p38 signaling and EGFR degradation and enhances response to cisplatin therapy in gynecologic cancers.

Kim KK, Han A, Yano N, Ribeiro JR, Lokich E, Singh RK, Moore RG. Kim KK, et al. Among authors: ribeiro jr. Sci Rep. 2015 Nov 16;5:15911. doi: 10.1038/srep15911. Sci Rep. 2015. PMID: 26568478 Free PMC article.

8

HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells.

James NE, Cantillo E, Oliver MT, Rowswell-Turner RB, Ribeiro JR, Kim KK, Chichester CO 3rd, DiSilvestro PA, Moore RG, Singh RK, Yano N, Zhao TC. James NE, et al. Among authors: ribeiro jr. Clin Exp Immunol. 2018 Sep;193(3):327-340. doi: 10.1111/cei.13153. Clin Exp Immunol. 2018. PMID: 29745428 Free PMC article.

9

Intratumoral expression analysis reveals that OX40 and TIM-3 are prominently expressed and have variable associations with clinical outcomes in high grade serous ovarian cancer.

James NE, Valenzuela AD, Emerson JB, Woodman M, Miller K, Hovanesian V, Ou J, Ribeiro JR. James NE, et al. Among authors: ribeiro jr. Oncol Lett. 2022 Jun;23(6):188. doi: 10.3892/ol.2022.13308. Epub 2022 Apr 26. Oncol Lett. 2022. PMID: 35527785 Free PMC article.

10

A bioinformatic analysis of WFDC2 (HE4) expression in high grade serous ovarian cancer reveals tumor-specific changes in metabolic and extracellular matrix gene expression.

James NE, Gura M, Woodman M, Freiman RN, Ribeiro JR. James NE, et al. Among authors: ribeiro jr. Med Oncol. 2022 May 15;39(5):71. doi: 10.1007/s12032-022-01665-4. Med Oncol. 2022. PMID: 35568777 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

419 results

Search Page